Read abstracts from the latest news in biosimilars.

First Trastuzumab Biosimilar, Ogivri, Approved by FDA

(FDA News Release, December 1, 2017)

3 Facts About Biosimilars Pharmacists Should Know

Pharmacy Times (03/08/16) Ross, Meghan

Amgen's Humira Biosimilar Accepted for FDA Review

Bloomberg BNA (01/26/16) Aquino, John T.

Biosimilar Issues on the FDA Guidance Agenda for 2016

U.S. Food and Drug Administration (01/22/2016)

Biosimilar Therapies in Inflammatory Bowel Disease: Should We Care About Patient Profile?

Expert Review of Clinical Immunology (02/16) Fiorino, Gionata; Fazio, Maria; Danese, Silvio

Biosimilars in Development Near End of Phase 3 Trials

Managed Care (02/01/16) Adams, Katherine T.

Biosimilars in the Management of Neutropenia: Focus on Filgrastim

Biologics: Targets and Therapy (02/18/2016) Vol. 10, P. 17; Caselli, D.; Cesaro, S.; Aricò, M.

Clinical and Regulatory Perspectives on Biosimilar Therapies and Intended Copies of Biologics in Rheumatology

Rheumatology International (02/27/2016) Mysler, E.; Pineda, C.; Horiuchi, T.

CMS Moves on Biosimilar Reimbursement

Pharmacy Practice News (01/29/16) Blum, Karen

Core Concepts: Biosimilars

Proceedings of the National Academy of Sciences (12/15/15) Vol. 112, No. 50, P. 15261; Ornes, Stephen

Development, Safety, and Efficacy of Biosimilar Adalimumab: The Data So Far

Biosimilars (01/29/2016) Vol. 06, P. 01; Gabbani, Tommaso; Deiana, Simona; Bagnoli, Siro

Evaluation of Immunogenicity of LY2963016 Insulin Glargine Compared With Lantus Insulin Glargine in Patients With Type 1 or Type 2 Diabetes Mellitus

Diabetes, Obesity, and Metabolism (02/01/2016) Vol. 18, No. 2, P. 159; Ilag, LL; Deeg, MA; Costigan, T

FDA Approval of a Biosimilar to Enbrel®

(FDA News Release, August 30, 2016)

Implementation of the Biosimilars Provisions of the ACA — Where Are We Now?

Health Affairs Blog (12/14/15) Wynne, Billy

Infliximab-qbtx Approved by FDA

(BUSINESS WIRE Release, December 13, 2017)

Nearly Half of U.S. Physicians Say They Will Prescribe More Biosimilars, According to New Data From InCrowd

Marketwired (03/03/16)

Test iFrame Safari


What Happened in Biosimilars During 2015

Generics and Biosimilars Initiative (GaBI) (01/22/2016)

New & Noteworthy